Safety Committee must meet tomorrow Wed? Well, seems to me that the safety committee must be meeting tomorrow, Wednesday. And that gives CYDY time to process the outcome of the safety committee meeting and fold it in with the mild/moderate results and release both on Thursday.

If indeed the safety committee meets, the safety committee is required to issue a stop or continue order for the severe/critical trial, I think. We can be very confident the safety committe is not going to halt the severe/critical trial because leronlimab is unsafe. So that leaves either stop the trial because leronlimab is working great or continue the trial because efficacy is not sufficiently established.

But I really don't know